In other tumor types, such as breast cancer [27], thyroid [16] or pancreatic cancer [28], similar sortilin expression profiles have been described, and targeting sortilin with specific pharmacological inhibitors has been shown to strongly reduce cancer cell migration and invasion. This evidence concerns the gene SORT1 and neoplasm.